openPR Logo
Press release

What's driving the Electrophysiology Devices Market Growth? Prominent Players: Abbott, Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Stereotaxis, Inc., AtriCure, Inc., AngioDynamics, Biotronik, Inc, Others

05-06-2020 01:20 PM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd.

What's driving the Electrophysiology Devices Market Growth?

The global electrophysiology devices market size is projected to reach USD 10.51 billion by 2026. According to a report published by Fortune Business Insights, titled "Electrophysiology Devices Market Size, Share & Industry Analysis, By Type (Ablation Catheters, Diagnostic Catheters, Mapping Systems, Accessories & Others), By Application (Atrial Fibrillation, Supraventricular Tachycardia (SVT), Ventricular Tachycardia, and Others), By End User (Hospitals & ASCs, and Specialty Clinics & Diagnostic Centres), and Regional Forecast, 2019-2026," the market size was USD 4.60 billion in 2018 and is projected to exhibit a CAGR of 10.9% during the forecast period.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/electrophysiology-devices-market-101730

Leading Players operating in the Electrophysiology Devices Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o Abbott
o Medtronic
o Boston Scientific Corporation
o Johnson & Johnson Services, Inc.
o Stereotaxis, Inc.
o AtriCure, Inc.
o AngioDynamics

o Biotronik, Inc

o Others
Increasing Number of Product Launches to Aid Growth
The report provides an in-depth analysis of the influence of major factors on the market in recent years. Among all factors, the increasing number of product launches have made the highest impact on the growth of the market in recent years. The report highlights a few of the major products of recent years. In September 2019, Biosense Webster Inc., announced the launch of CARTONET. The device was the world's first secure cloud-based network, aimed to review and analyze atrial fibrillation cases. The device successfully enhanced the overall efficiency of the procedure. Abbott's new electrophysiology mapping catheter system was another product that has made a positive impact on the market in recent years.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/electrophysiology-devices-market-101730

Detailed Table of Content:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Detailed Product Mapping By Key Market Players
4.2 Prevalence of Tachycardia by Key Regions/ Key Countries, 2018
4.3 Technological Advancements in Electrophysiology Devices
4.4 Key industry Developments - Mergers, Acquisitions and Partnerships
5. Global Electrophysiology Devices Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast - By Type
5.2.1 Ablation Catheters
5.2.2 Diagnostic Catheters
5.2.3 Mapping System
5.2.4 Accessories
5.2.5 Others
5.3. Market Analysis, Insights and Forecast - By Application
5.3.1 Atrial Fibrillation
5.3.2 Supraventricular Tachycardia (SVT)
5.3.3 Ventricular Tachycardia
5.3.4 Others
5.4. Market Analysis, Insights and Forecast - By End User
5.4.1 Hospitals & ASC's
5.4.2 Specialty Clinics & Diagnostic Centers
5.5. Market Analysis, Insights and Forecast - By Region
5.5.1 North America
5.5.2 Europe
5.5.3 Asia Pacific
5.5.4 Latin America
5.5.5 Middle East & Africa
6. North America Electrophysiology Devices Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast - By Type
6.2.1 Ablation Catheters
6.2.2 Diagnostic Catheters
6.2.3 Mapping System
6.2.4 Accessories
6.2.5 Others
6.3. Market Analysis, Insights and Forecast - By Application
6.3.1 Atrial Fibrillation
6.3.2 Supraventricular Tachycardia (SVT)
6.3.3 Ventricular Tachycardia
6.3.3 Others
6.4. Market Analysis, Insights and Forecast - By End User
6.4.1 Hospitals & ASC's
6.4.2 Specialty Clinics & Diagnostic Centers
6.5. Market Analysis, Insights and Forecast - By Country
6.5.1 U.S.
6.5.2 Canada
7. Europe Electrophysiology Devices Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast - By Type
7.2.1 Ablation Catheters
7.2.2 Diagnostic Catheters
7.2.3 Mapping System
7.2.4 Accessories
7.2.5 Others
7.3. Market Analysis, Insights and Forecast - By Application
7.3.1 Atrial Fibrillation
7.3.2 Supraventricular Tachycardia (SVT)
7.3.3 Ventricular Tachycardia
7.3.3 Others
7.4. Market Analysis, Insights and Forecast - By End User
7.4.1 Hospitals & ASC's
7.4.2 Specialty Clinics & Diagnostic Centers
7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
7.5.1 U.K.
7.5.2 Germany
7.5.3 France
7.5.4 Spain
7.5.5 Italy
7.5.6 Scandinavia
7.5.7 Rest of Europe
8. Asia Pacific Electrophysiology Devices Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast - By Type
8.2.1 Ablation Catheters
8.2.2 Diagnostic Catheters
8.2.3 Mapping System
8.2.4 Accessories
8.2.5 Others
8.3. Market Analysis, Insights and Forecast - By Application
8.3.1 Atrial Fibrillation
8.3.2 Supraventricular Tachycardia (SVT)
8.3.3 Ventricular Tachycardia
8.3.3 Others
8.4. Market Analysis, Insights and Forecast - By End User
8.4.1 Hospitals & ASC's
8.4.2 Specialty Clinics & Diagnostic Centers
8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
8.5.1 Japan
8.5.2 China
8.5.3 India
8.5.4 Australia
8.5.5 Southeast Asia
8.5.6 Rest of Asia Pacific
Continued...

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Electrophysiology Devices Market Growth? Prominent Players: Abbott, Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Stereotaxis, Inc., AtriCure, Inc., AngioDynamics, Biotronik, Inc, Others here

News-ID: 2036182 • Views:

More Releases from Fortune Business Insights Pvt. Ltd.

Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% CAGR During the Forecast Period
Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% …
The global bread maker market size was valued at USD 7.48 billion in 2023 and is expected to be worth USD 7.70 billion in 2024. The market is projected to reach USD 11.13 billion by 2032, recording a CAGR of 4.71% during the forecast period. Bread maker machines enable users to create a diverse range of bread at home cost-effectively. The increasing demand for innovative home appliances and the rising replacement
Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Forecast Period.
Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Foreca …
The global streetwear market size was valued at USD 325.28 billion in 2023. The market is projected to be worth USD 347.14 billion in 2024 and reach USD 637.13 billion by 2032, exhibiting a CAGR of 7.89% during the forecast period. Asia Pacific dominated the streetwear market with a market share of 36.17% in 2023. Fortune Business InsightsTM displays this information in a report titled, "Streetwear Market, 2024-2032." Request a Free Sample
Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Companies- Nike, Supreme, Stussy, BAPE
Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Compan …
The streetwear market size was valued at USD 325.28 billion in 2023 and is expected to be worth USD 347.14 billion in 2024. The market is projected to reach USD 637.13 billion by 2032, recording a CAGR of 7.89% during the forecast period. Streetwear is youth-inspired clothing that is highly popular among hip-hop enthusiasts and skateboarders. It is popular for its vibrant colors, bold logo graphics, and unconventional designs. Streetwear is
Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- L'Oréal S.A.( France), Unilever Plc (U.K.), Coty Inc. (U.S.)
Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- …
The global perfume market size was valued at USD 48.05 billion in 2023 and is projected to grow from USD 50.45 billion in 2024 to USD 77.52 billion by 2032, exhibiting a CAGR of 5.51% during the forecast period. Perfumes are pleasant smelling solutions made by using oils, fragrances, and other ingredients to create a pleasing aroma. Increasing demand for high-quality beauty and grooming products globally is expected to boost the

All 5 Releases


More Releases for Tachycardia

Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Research Repor …
Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. View Sample Report https://reports.valuates.com/request/sample/QYRE-Auto-29X6020/Global_Postural_Orthostatic_Tachycardia_Syndrome_POTS_Treatment_Market_Insights_Forecast_to_2028 Report Scope The diagnosis of Postural Orthostatic Tachycardia Syndrome (POTS) has significantly increased due to advances in medical research and increased awareness among healthcare practitioners. There is now a greater need for treatment choices as a result of the condition's improved identification
Esmolol Hydrochloride Market Report 2018: Segmentation by Indication (Supraventr …
Global Esmolol Hydrochloride market research report provides company profile for APP Pharmaceuticals Manufacturing, LLC, Hikma Pharmaceuticals PLC, Baxter International Inc., General Injectables and Vaccines, Inc., Bayer AG, and Bioniche Pharma USA Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR
Tachycardia Market share will expand till 2016 - 2024
Tachycardia Market: Overview Tachycardia refers to rapid abnormal heartbeat that exceeds the normal heartbeat range and the irregular heart rhythm is usually more than 100 beats per minute. Due to higher-than-normal heartbeat, there is an increase in the need for oxygen by the heart muscle and the heart is not able to pump oxygenated blood to the body efficiently. Reaction to certain medications, heart abnormalities, coronary artery diseases, heart muscle diseases,
Tachycardia Market : Industry Insights With Key Company Profiles - Forecast To 2 …
Tachycardia Market: Overview Tachycardia refers to rapid abnormal heartbeat that exceeds the normal heartbeat range and the irregular heart rhythm is usually more than 100 beats per minute. Due to higher-than-normal heartbeat, there is an increase in the need for oxygen by the heart muscle and the heart is not able to pump oxygenated blood to the body efficiently. Reaction to certain medications, heart abnormalities, coronary artery diseases, heart muscle diseases,
Ventricular Tachycardia Industry Pipeline Review H1 2017 - Orbis Research
Ventricular Tachycardia - Pipeline Review, H1 2017, provides an overview of the Ventricular Tachycardia (Cardiovascular) pipeline landscape. Ventricular tachycardia is a very fast heart rhythm that begins in the ventricles. Symptoms of ventricular tachycardia include dizziness, fainting, fatigue, chest pain and shortness of breath. Causes include cardiomyopathy, ischemic heart disease and heart failure. Risk factors include age, family history and medical history. Treatment includes antiarrhythmic medication. Request a sample of this report
Forecast Upto 2024 For Tachycardia Market And New Research Report
Tachycardia Market: Overview Tachycardia refers to rapid abnormal heartbeat that exceeds the normal heartbeat range and the irregular heart rhythm is usually more than 100 beats per minute. Due to higher-than-normal heartbeat, there is an increase in the need for oxygen by the heart muscle and the heart is not able to pump oxygenated blood to the body efficiently. Reaction to certain medications, heart abnormalities, coronary artery diseases, heart muscle diseases,